Clinical-stage oncology company developing sonodynamic therapy (SDT), a non-invasive drug-device combination that pairs SONALA-001 with ultrasound to treat cancers
Clinical-stage oncology company developing sonodynamic therapy (SDT), a non-invasive drug-device combination that pairs SONALA-001 with ultrasound to treat cancers. Its clinical programs include recurrent high-grade glioma and diffuse intrinsic pontine glioma (DIPG), with additional tumor indications under development.